Finance

Lists
0NF1:FRA
Noveris Health Sciences Inc
€0.094
+6.78%
(+0.0060) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 0NF1...
Open
€0.08
High
€0.10
Low
€0.08
Mkt. cap
6.45M
Avg. vol.
39.52K
Volume
77.84K
52-wk high
€1.81
52-wk low
€0.05
No. of employees
3
Open
€0.08
High
€0.10
Low
€0.08
Mkt. cap
6.45M
Avg. vol.
39.52K
Volume
77.84K
52-wk high
€1.81
52-wk low
€0.05
No. of employees
3
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-40.14K
-
-
32.79K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-70.57K
5.04K
316.29K
669.62K
Operating expense
-110.70K
5.04K
316.29K
702.42K
Total operating expenses
-110.70K
5.04K
316.29K
702.42K
Operating income
110.70K
-5.04K
-316.29K
-702.42K
Other non operating income
85.53K
-417.63K
-1.32M
640.56K
EBT including unusual items
73.79K
3.16M
-1.62M
22.81K
EBT excluding unusual items
73.79K
-405.27K
-1.62M
-155.29K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
73.79K
3.16M
-1.62M
22.81K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26.16K
-12.63K
-9.90K
Net interest expenses
-
-26.16K
-12.63K
-9.90K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps